Phenotypic heterogeneity in 22q11.2 deletion syndrome: Copy Number Variants as genetic modifiers for congenital heart disease in a Brazilian cohort
American Journal of Medical Genetics Part A · 2023-05 · 191 (5) · 1273-1281
DOI: 10.1002/ajmg.a.63145 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, online erschienen am 07.02.2023. Verfasst von M Zamariolli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Division, Universidade Federal de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: DiGeorge Syndrome, Heart Defects, Congenital. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo.
Abstract (Originalsprache)
The clinical heterogeneity in 22q11.2 deletion syndrome (22q11.2DS) underlies complex genetic mechanisms including variants in other regions of the genome, known as genetic modifiers. Congenital heart disease (CHD) is one of the most relevant phenotypes in the syndrome and copy number variants (CNVs) outside the 22q11.2 region could play a role in its variable expressivity. Since those described loci account for a small proportion of the variability, the CNV analysis in new cohorts from different ancestry‐based populations constitutes a valuable resource to identify a wider range of modifiers. We performed SNP‐array in 117 Brazilian patients with 22q11.2DS, with and without CHD, and leveraged genome‐wide CNV analysis. After quality control, we selected 50 CNVs in 38 patients for downstream analysis. CNVs' genetic content and implicated biological pathways were compared between patients with and without CHD. CNV‐affected genes in patients with CHD were enriched for several functional terms related to ubiquitination, transcription factor binding sites and miRNA targets, highlighting the complexity of the phenotype's expressivity. Cardiac‐related genes were identified in both groups of patients suggesting that increasing risk and protective mechanisms could be involved. These genes and enriched pathways could indicate new modifiers to the cardiac phenotype in 22q11.2DS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genetic Division, Universidade Federal de São Paulo, São Paulo, Brazil.
- Sleep Institute, São Paulo, Brazil.
- Department of Translational Medicine, Area of Medical Genetics and Genomic Medicine, Universidade Estadual de Campinas, Campinas, Brazil.
- Genetics Unit, Instituto da Criança, Universidade de São Paulo, São Paulo, Brazil.
ORCID-Profile: M I Melaragno
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
Zitieren
APA
Zamariolli, M., Dantas, A. G., Nunes, N., Moysés-Oliveira, M., Sgardioli, I. C., Soares, D. C. Q., Gil-Da-Silva-Lopes, V. L., Kim, C. A., & Melaragno, M. I. (2023). Phenotypic heterogeneity in 22q11.2 deletion syndrome: Copy Number Variants as genetic modifiers for congenital heart disease in a Brazilian cohort. American Journal of Medical Genetics Part A, 191(5), 1273-1281. https://doi.org/10.1002/ajmg.a.63145
Vancouver
Zamariolli M, Dantas AG, Nunes N, Moysés-Oliveira M, Sgardioli IC, Soares DCQ, et al. Phenotypic heterogeneity in 22q11.2 deletion syndrome: Copy Number Variants as genetic modifiers for congenital heart disease in a Brazilian cohort. American Journal of Medical Genetics Part A. 2023;191(5):1273-1281. doi:10.1002/ajmg.a.63145
BibTeX
@article{Zamariolli2023,
author = {Zamariolli, M and Dantas, A G and Nunes, N and Moysés-Oliveira, M and Sgardioli, I C and Soares, D C Q and Gil-Da-Silva-Lopes, V L and Kim, C A and Melaragno, M I},
title = {Phenotypic heterogeneity in 22q11.2 deletion syndrome: Copy Number Variants as genetic modifiers for congenital heart disease in a Brazilian cohort},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
volume = {191},
number = {5},
pages = {1273--1281},
doi = {10.1002/ajmg.a.63145}
}
EUVIMED